Vitamin A plus measles vaccination: the downside of convenience?
Identifieur interne : 001335 ( Main/Exploration ); précédent : 001334; suivant : 001336Vitamin A plus measles vaccination: the downside of convenience?
Auteurs : David Ross [Royaume-Uni]Source :
- The Lancet [ 0140-6736 ] ; 1995.
Descripteurs français
- Wicri :
- topic : Politique de la santé, Vaccination, Vaccin, Vitamine.
English descriptors
- KwdEn :
- Aids research, Attenuated, Attenuated virus, Discussion document, Group meeting, Health policy, Immunisation, Immunisation programmes, Immunization, Immunization contacts, Lower proportion, Maternal antibody, Measles, Measles antibody, Measles vaccination, Measles vaccine, Oxford university press, Programme, Same time, Significant levels, Supplementation, Vaccination, Vaccine, Vitamin, Widespread introduction, World bank, World health, World health organization.
- Teeft :
- Aids research, Attenuated, Attenuated virus, Discussion document, Group meeting, Health policy, Immunisation, Immunisation programmes, Immunization, Immunization contacts, Lower proportion, Maternal antibody, Measles, Measles antibody, Measles vaccination, Measles vaccine, Oxford university press, Programme, Same time, Significant levels, Supplementation, Vaccination, Vaccine, Vitamin, Widespread introduction, World bank, World health, World health organization.
Url:
DOI: 10.1016/S0140-6736(95)92531-7
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000348
- to stream Istex, to step Curation: 000348
- to stream Istex, to step Checkpoint: 000786
- to stream Main, to step Merge: 001445
- to stream Main, to step Curation: 001335
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Vitamin A plus measles vaccination: the downside of convenience?</title><author><name sortKey="Ross, David" sort="Ross, David" uniqKey="Ross D" first="David" last="Ross">David Ross</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3F1E9E4506EAD4A8510D0BC2073CCFA4866CE5F9</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1016/S0140-6736(95)92531-7</idno><idno type="url">https://api.istex.fr/document/3F1E9E4506EAD4A8510D0BC2073CCFA4866CE5F9/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000348</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000348</idno><idno type="wicri:Area/Istex/Curation">000348</idno><idno type="wicri:Area/Istex/Checkpoint">000786</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000786</idno><idno type="wicri:doubleKey">0140-6736:1995:Ross D:vitamin:a:plus</idno><idno type="wicri:Area/Main/Merge">001445</idno><idno type="wicri:Area/Main/Curation">001335</idno><idno type="wicri:Area/Main/Exploration">001335</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Vitamin A plus measles vaccination: the downside of convenience?</title><author><name sortKey="Ross, David" sort="Ross, David" uniqKey="Ross D" first="David" last="Ross">David Ross</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Maternal and Child Epidemiology Unit, London School of Hygiene and Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">The Lancet</title><title level="j" type="abbrev">LANCET</title><idno type="ISSN">0140-6736</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1995">1995</date><biblScope unit="volume">345</biblScope><biblScope unit="issue">8961</biblScope><biblScope unit="page" from="1317">1317</biblScope><biblScope unit="page" to="1318">1318</biblScope></imprint><idno type="ISSN">0140-6736</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0140-6736</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aids research</term><term>Attenuated</term><term>Attenuated virus</term><term>Discussion document</term><term>Group meeting</term><term>Health policy</term><term>Immunisation</term><term>Immunisation programmes</term><term>Immunization</term><term>Immunization contacts</term><term>Lower proportion</term><term>Maternal antibody</term><term>Measles</term><term>Measles antibody</term><term>Measles vaccination</term><term>Measles vaccine</term><term>Oxford university press</term><term>Programme</term><term>Same time</term><term>Significant levels</term><term>Supplementation</term><term>Vaccination</term><term>Vaccine</term><term>Vitamin</term><term>Widespread introduction</term><term>World bank</term><term>World health</term><term>World health organization</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Aids research</term><term>Attenuated</term><term>Attenuated virus</term><term>Discussion document</term><term>Group meeting</term><term>Health policy</term><term>Immunisation</term><term>Immunisation programmes</term><term>Immunization</term><term>Immunization contacts</term><term>Lower proportion</term><term>Maternal antibody</term><term>Measles</term><term>Measles antibody</term><term>Measles vaccination</term><term>Measles vaccine</term><term>Oxford university press</term><term>Programme</term><term>Same time</term><term>Significant levels</term><term>Supplementation</term><term>Vaccination</term><term>Vaccine</term><term>Vitamin</term><term>Widespread introduction</term><term>World bank</term><term>World health</term><term>World health organization</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Politique de la santé</term><term>Vaccination</term><term>Vaccin</term><term>Vitamine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Ross, David" sort="Ross, David" uniqKey="Ross D" first="David" last="Ross">David Ross</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001335 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001335 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3F1E9E4506EAD4A8510D0BC2073CCFA4866CE5F9
|texte= Vitamin A plus measles vaccination: the downside of convenience?
}}
| This area was generated with Dilib version V0.6.31. |  |